282 related articles for article (PubMed ID: 29735543)
21. The RASSF1A tumor suppressor activates Bax via MOAP-1.
Vos MD; Dallol A; Eckfeld K; Allen NP; Donninger H; Hesson LB; Calvisi D; Latif F; Clark GJ
J Biol Chem; 2006 Feb; 281(8):4557-63. PubMed ID: 16344548
[TBL] [Abstract][Full Text] [Related]
22. Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo.
Elsum IA; Yates LL; Pearson HB; Phesse TJ; Long F; O'Donoghue R; Ernst M; Cullinane C; Humbert PO
Oncogene; 2014 Nov; 33(48):5523-33. PubMed ID: 24276238
[TBL] [Abstract][Full Text] [Related]
23. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.
Minai-Tehrani A; Chang SH; Kwon JT; Hwang SK; Kim JE; Shin JY; Yu KN; Park SJ; Jiang HL; Kim JH; Hong SH; Kang B; Kim D; Chae CH; Lee KH; Beck GR; Cho MH
Cell Oncol (Dordr); 2013 Feb; 36(1):15-26. PubMed ID: 23070870
[TBL] [Abstract][Full Text] [Related]
24. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
Talluri S; Francis SM; Dick FA
PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
[TBL] [Abstract][Full Text] [Related]
25. Ras signaling through RASSF proteins.
Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
[TBL] [Abstract][Full Text] [Related]
26. In vivo CRISPR screening unveils histone demethylase UTX as an important epigenetic regulator in lung tumorigenesis.
Wu Q; Tian Y; Zhang J; Tong X; Huang H; Li S; Zhao H; Tang Y; Yuan C; Wang K; Fang Z; Gao L; Hu X; Li F; Qin Z; Yao S; Chen T; Chen H; Zhang G; Liu W; Sun Y; Chen L; Wong KK; Ge K; Chen L; Ji H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E3978-E3986. PubMed ID: 29632194
[TBL] [Abstract][Full Text] [Related]
27. K-ras mutations and RASSF1A promoter methylation in colorectal cancer.
van Engeland M; Roemen GM; Brink M; Pachen MM; Weijenberg MP; de Bruïne AP; Arends JW; van den Brandt PA; de Goeij AF; Herman JG
Oncogene; 2002 May; 21(23):3792-5. PubMed ID: 12032847
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Liver Tumor-Prone Mouse Models of the Hippo Kinase Scaffold Proteins RASSF1A and SAV1.
Zhang X; Guo C; Wu X; Li AX; Liu L; Tsark W; Dammann R; Shen H; Vonderfecht SL; Pfeifer GP
Cancer Res; 2016 May; 76(9):2824-35. PubMed ID: 26980762
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.
Qu Z; Sun F; Zhou J; Li L; Shapiro SD; Xiao G
Cancer Res; 2015 Aug; 75(16):3209-15. PubMed ID: 26122841
[TBL] [Abstract][Full Text] [Related]
30.
Lee YS; Lee JY; Song SH; Kim DM; Lee JW; Chi XZ; Ito Y; Bae SC
Mol Cells; 2020 Oct; 43(10):889-897. PubMed ID: 33115981
[No Abstract] [Full Text] [Related]
31. Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers.
Divine KK; Pulling LC; Marron-Terada PG; Liechty KC; Kang T; Schwartz AG; Bocklage TJ; Coons TA; Gilliland FD; Belinsky SA
Int J Cancer; 2005 Apr; 114(3):400-5. PubMed ID: 15578700
[TBL] [Abstract][Full Text] [Related]
32. [Meta-analysis of the Association between RASSF1A Gene Promoter Methylation and Non-small Cell Lung Cancer].
Wei H; Fang N; Guo L; Wu Z; Zhou Q
Zhongguo Fei Ai Za Zhi; 2015 Jul; 18(7):443-50. PubMed ID: 26182870
[TBL] [Abstract][Full Text] [Related]
33. Caveolin-1 promotes the tumor suppressor properties of oncogene-induced cellular senescence.
Volonte D; Vyas AR; Chen C; Dacic S; Stabile LP; Kurland BF; Abberbock SR; Burns TF; Herman JG; Di YP; Galbiati F
J Biol Chem; 2018 Feb; 293(5):1794-1809. PubMed ID: 29247004
[TBL] [Abstract][Full Text] [Related]
34. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis.
Zhou C; Licciulli S; Avila JL; Cho M; Troutman S; Jiang P; Kossenkov AV; Showe LC; Liu Q; Vachani A; Albelda SM; Kissil JL
Oncogene; 2013 Feb; 32(7):903-9. PubMed ID: 22430205
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor RASSF1A in human carcinogenesis: an update.
Dammann R; Schagdarsurengin U; Seidel C; Strunnikova M; Rastetter M; Baier K; Pfeifer GP
Histol Histopathol; 2005 Apr; 20(2):645-63. PubMed ID: 15736067
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma.
Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J
Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441
[TBL] [Abstract][Full Text] [Related]
37. Chromosomal instability suppresses the growth of K-Ras-induced lung adenomas.
Laucius CD; Orr B; Compton DA
Cell Cycle; 2019 Aug; 18(15):1702-1713. PubMed ID: 31179849
[TBL] [Abstract][Full Text] [Related]
38. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.
Keller M; Dubois F; Teulier S; Martin APJ; Levallet J; Maille E; Brosseau S; Elie N; Hergovich A; Bergot E; Camonis J; Zalcman G; Levallet G
J Exp Clin Cancer Res; 2019 Apr; 38(1):158. PubMed ID: 30979377
[TBL] [Abstract][Full Text] [Related]
39. RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway.
Dubois F; Keller M; Calvayrac O; Soncin F; Hoa L; Hergovich A; Parrini MC; Mazières J; Vaisse-Lesteven M; Camonis J; Levallet G; Zalcman G
Cancer Res; 2016 Mar; 76(6):1627-40. PubMed ID: 26759237
[TBL] [Abstract][Full Text] [Related]
40. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
